statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	784
RU - Federazione Russa	197
SG - Singapore	113
IE - Irlanda	90
CN - Cina	88
IT - Italia	77
BR - Brasile	47
VN - Vietnam	39
DE - Germania	31
FI - Finlandia	26
GB - Regno Unito	26
HK - Hong Kong	26
FR - Francia	25
SE - Svezia	18
ZA - Sudafrica	13
KR - Corea	12
CA - Canada	11
CZ - Repubblica Ceca	7
IN - India	6
PL - Polonia	6
BD - Bangladesh	5
MX - Messico	5
ES - Italia	4
JP - Giappone	4
KE - Kenya	4
AE - Emirati Arabi Uniti	3
AZ - Azerbaigian	3
EG - Egitto	3
IR - Iran	3
JO - Giordania	3
PK - Pakistan	3
TR - Turchia	3
AR - Argentina	2
AT - Austria	2
CI - Costa d'Avorio	2
EC - Ecuador	2
HN - Honduras	2
IQ - Iraq	2
NL - Olanda	2
TN - Tunisia	2
UA - Ucraina	2
AL - Albania	1
AU - Australia	1
BO - Bolivia	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
GE - Georgia	1
ID - Indonesia	1
JM - Giamaica	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
MU - Mauritius	1
MY - Malesia	1
NI - Nicaragua	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.728

Nome	#
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction	428
ADONHERS (Aged DONor HEart Rescue by Stress Echo) National Protocol: Recipient's Survival after 10-Year Follow-Up	196
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study	159
Two and Three-Dimensional Echocardiography in Primary Mitral Regurgitation: Practical Hints to Optimize the Surgical Planning	148
The role of non-invasive imaging modalities in cardiac allograft vasculopathy: an updated focus on current evidences	147
Risk stratification in cardiogenic shock: a focus on the available evidence	145
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization	129
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence	123
Current and emerging drug targets in heart failure treatment	111
Epidemiological and clinical boundaries of heart failure with preserved ejection fraction	99
Strain echocardiography for the prognostic estimation of patients with sarcoidosis	96
Totale	1.781

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	51	0	0	0	0	0	0	17	7	0	5	8	14
2022/2023	135	5	12	12	9	11	17	8	15	10	8	6	22
2023/2024	176	10	8	20	20	8	30	67	1	1	5	0	6
2024/2025	359	16	12	36	13	52	27	14	18	40	20	35	76
2025/2026	1.060	64	95	421	95	183	26	71	15	22	46	17	5
Totale													1.781